Literature DB >> 7691675

Nitric oxide synthase distribution in the enteric nervous system of Hirschsprung's disease.

J M Vanderwinden1, M H De Laet, S N Schiffmann, P Mailleux, C J Lowenstein, S H Snyder, J J Vanderhaeghen.   

Abstract

BACKGROUND: Hirschsprung's disease is characterized histologically by aganglionosis and functionally by impaired relaxation of the gut. Nitric oxide has recently been described pharmacologically as a major inhibitory mediator in the gut musculature in laboratory animals. The present study hypothesized that NO could be involved in motility disorders of the human gut. The aim was to study the neuronal enzyme synthetizing NO in the ganglionic and aganglionic human gut.
METHODS: Reduced nicotinamide adenine dinucleotide phosphate-diaphorase histochemistry and immunohistochemistry with a specific polyclonal antiserum were used to examine NO synthase distribution in the enteric nervous system in six patients with Hirschsprung's disease and five control patients.
RESULTS: NO synthase was selectively absent in the plexus area and in the musculature of the aganglionic segments, whereas moderate staining was observed in the hypertrophied nerve bundles in the submucosa. In contrast, in the ganglionic segment NO synthase was abundantly present, in a pattern similar to that of the normal colon.
CONCLUSIONS: These findings suggest the involvement of NO in the physiopathology of Hirschsprung's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691675     DOI: 10.1016/0016-5085(93)90938-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

Review 1.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Basal internal anal sphincter tone, inhibitory neurotransmission, and other factors contributing to the maintenance of high pressures in the anal canal.

Authors:  S Rattan; J Singh
Journal:  Neurogastroenterol Motil       Date:  2011-01       Impact factor: 3.598

Review 3.  Enteric nervous system and developmental abnormalities in childhood.

Authors:  Thambipillai Sri Paran; Udo Rolle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2006-12       Impact factor: 1.827

4.  Neurochemical coding of the enteric nervous system in chagasic patients with megacolon.

Authors:  A B M da Silveira; D D'Avila Reis; E C de Oliveira; S G Neto; A O Luquetti; D Poole; R Correa-Oliveira; J B Furness
Journal:  Dig Dis Sci       Date:  2007-03-24       Impact factor: 3.199

5.  Deficiency of purinergic P2Y receptors in aganglionic intestine in Hirschsprung's disease.

Authors:  Anne-Marie O' Donnell; Prem Puri
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

6.  Distribution of nitric oxide synthase-containing nerves in the aganglionic intestine of mutant rats: a histochemical study.

Authors:  M Teramoto; T Domoto; K Tanigawa; Y Yasui; K Tamura
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

7.  Cholinergic stimulation and nonadrenergic, noncholinergic relaxation of human colonic circular muscle in idiopathic chronic constipation.

Authors:  D Mitolo-Chieppa; G Mansi; R Rinaldi; M Montagnani; M A Potenza; M Genualdo; M Serio; C I Mitolo; M Rinaldi; D F Altomare; V Memeo
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

8.  The distribution and co-localization of nitric oxide synthase and vasoactive intestinal polypeptide in nerves of the colons with Hirschsprung's disease.

Authors:  R Guo; O Nada; S Suita; T Taguchi; K Masumoto
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

Review 9.  Hirschprung's disease.

Authors:  P B Sullivan
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

10.  Tetrahydrobiopterin regulates cyclic GMP-dependent electrogenic Cl- secretion in mouse ileum in vitro.

Authors:  V E Rolfe; M P Brand; S J Heales; K J Lindley; P J Milla
Journal:  J Physiol       Date:  1997-09-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.